Funding for 300 thousand Euros, granted by Monte dei Paschi di Siena Bank and guaranteed by SACE through the “2nd Program for Enterprise” CDP, SACE and EIF (EIB Group), which provides funds to Italian companies through the Juncker Plan, for the opening of a subsidiary in the United Kingdom for commercial activity development.
SACE (CDP Group) and Banca Monte dei Paschi di Siena finalized a credit line of 300 thousand euro to support the internationalization development – precisely on the UK market – of Kelyon, a in digital health company, specializing in the design and development of software medical devices.
The initiative is organized under the “2nd program for Enterprise” CDP, SACE and EIF (EIB Group) which aims to support Italian SMEs and their internationalization and innovation projects through the resources of the Juncker Plan and was supported by the financial advisor FC & Partners.
Kelyon – which produces a third of its revenues abroad, and counts some of the biggest multinational pharmaceutical companies among its clients – has formed a new company in the UK to develop its business on the British market and to create new and profitable partnerships with universities in the Country, a first, important step in the expansion throughout Europe and North America. The English subsidiary, therefore, will aim to grow an SME like Kelyon on international markets, seizing new business opportunities.
The credit line will allow Kelyon to bear the opening and start-up costs of the new structure. This loan is the first to benefit from the “InnovFin” guarantee in the Lazio Region issued by the European Investment Fund (“EIF”) with the European Union financial support in the terms defined within the Horizon 2020 program and the European Fund for Strategic Investments (“EFSI”). The purpose of EFSI is to help companies access financing and implement productive investments in the European Union as well as to ensure greater access to finance.
For more information, read the official Press release
